past
decad
structurebas
drug
design
play
increasingli
import
role
drug
develop
end
consider
effort
resourc
devot
solv
import
protein
structur
human
pathogen
van
voorhi
et
al
lead
establish
sever
structur
genom
consortia
first
group
structur
genom
pathogen
protozoa
consortium
sgpp
http
wwwsgpporg
solv
structur
protein
pathogen
protozoa
develop
method
insight
subsequ
use
medic
structur
genom
pathogen
protozoa
project
msgpp
http
wwwmsgpporg
develop
novel
antiprotozoan
drug
fan
et
al
tuberculosi
structur
genom
consortium
tbsgc
http
wwwwebtborg
unifi
core
facil
servic
individu
laboratori
focus
structur
determin
metabol
function
import
protein
mycobacterium
tuberculosi
aid
drug
discoveri
gould
et
al
terwillig
et
al
although
structur
genom
consortium
sgc
http
wwwsgcutorontoca
focus
heavili
human
diseas
protein
group
also
studi
kinas
cylophilin
ubiquitinconjug
enzym
number
salvag
biosynthesi
pathway
eukaryot
parasit
includ
trypanosom
plasmodium
falciparum
apicomplexan
orthologu
gileadi
et
al
bochkarev
tempel
viral
infect
structur
proteom
visp
center
http
vispscrippsedudefaultaspx
solv
protein
structur
sarscov
influenza
herpesvirus
flavivirus
addit
biolog
commun
nomin
number
microbi
target
structur
solut
protein
structur
initi
psi
network
http
wwwsbkborg
particular
midwest
center
structur
genom
mcsg
http
wwwmcsganlgov
address
protein
relat
pathogenesi
metabol
host
interact
diseas
lee
et
al
septemb
cumul
effort
individu
research
laboratori
result
protein
data
bank
entri
protein
pathogen
organ
niaid
categori
b
c
prioriti
pathogen
list
exclud
escherichia
coli
late
nation
institut
allergi
infecti
diseas
niaid
provid
fund
seattl
structur
genom
center
infecti
diseas
ssgcid
http
wwwssgcidorg
center
structur
genom
infecti
diseas
csgid
http
wwwcsgidorg
solv
protein
structur
potenti
bioterror
agent
emerg
reemerg
infecti
diseas
organ
myler
et
al
anderson
organ
includ
differ
genera
bacteria
eukaryot
virus
divid
two
center
strive
meet
need
infecti
diseas
research
within
greater
scientif
commun
ssgcid
interact
heavili
academ
collabor
solicit
target
nomin
freeli
provid
structur
data
well
clone
purifi
protein
laboratori
materi
primari
research
purpos
myler
et
al
work
ssgcid
csgid
special
center
repres
increas
focu
within
nation
institut
health
address
broad
rang
biolog
problem
relev
particular
sector
scientif
investig
thu
ssgcid
repres
uniqu
structur
biolog
resourc
research
focus
discoveri
develop
novel
cure
treatment
infecti
diseas
ssgcid
focus
structuredetermin
effort
eight
genera
bacteria
bartonella
brucella
ehrlichia
anaplasma
rickettsia
burkholderia
mycobacterium
borrelia
nine
speci
eukaryot
pathogen
acanthamoeba
babesia
cryptosporidium
cyclospora
toxoplasma
giardia
entamoeba
coccidioid
encephalitozoon
negativestrand
rna
virus
marburg
viru
ebolalik
viru
influenza
b
c
virus
arenaviru
hantaviru
henipaviru
lyssaviru
nairoviru
orthobunyaviru
phleboviru
rubulaviru
one
singlestrand
dna
viru
erythroviru
date
total
target
speci
within
genera
valid
approv
ssgcid
pipelin
outset
project
ssgcid
bioinformat
team
select
sever
thousand
protein
thought
repres
drug
target
ssgcid
target
organ
sinc
play
key
role
identifi
marker
infect
reproduct
growth
drug
resist
bacteri
eukaryot
pathogen
initi
target
select
made
identifi
homologu
potenti
drug
target
singl
repres
speciesstrain
genu
base
similar
target
drugbank
databas
http
wwwdrugbankca
addit
detail
cover
initi
targetselect
approach
includ
bioinformat
filter
util
describ
previous
myler
et
al
target
select
ssgcid
also
includ
rescu
attempt
fail
target
select
orthologu
paralogu
speci
within
niaidapprov
genera
perform
eight
mycobacterium
genom
abscessu
avium
bovi
lepra
marinum
paratuberculosi
smegmati
thermoresistibil
order
character
homologu
tuberculosi
target
fail
stage
within
ssgcid
pipelin
also
use
bioinformat
approach
util
statist
classif
algorithm
cadag
et
al
identifi
protein
predict
associ
virul
andor
pathogenesi
viral
genom
contain
substanti
fewer
proteincod
gene
bacteri
eukaryot
pathogen
therefor
differ
approach
adopt
target
select
genera
follow
recommend
viral
research
commun
focus
two
potenti
drug
target
involv
viral
replic
nucleoprotein
n
rnadepend
rna
polymeras
l
orthologu
target
select
sever
genera
speci
strain
viru
famili
strategi
alreadi
appli
bunyavirida
paramyxovirida
rhabdovirida
famili
extend
arenavirida
orthomyxovirida
parvovirida
awar
ssgcid
permeat
scientif
commun
pipelin
intern
select
target
becom
supplement
increas
number
target
request
commun
research
interact
collabor
research
continu
influenc
ssgcid
pipelin
lead
select
entir
biolog
pathway
appear
essenti
one
pathogen
organ
instanc
sever
commun
request
includ
seven
enzym
methylerythritol
phosphat
mep
pathway
isoprenoid
biosynthesi
number
bacteri
protozoan
speci
enzym
pathway
demonstr
essenti
malaria
tuberculosi
varieti
protozoan
bacteri
organ
contrast
mevalonatedepend
pathway
present
human
rohmer
et
al
jomaa
et
al
eisenreich
et
al
hunter
ssgcid
also
expand
beyond
protein
includ
small
number
noncod
rna
molecul
bacteri
thibox
samii
riboswitch
structur
determin
work
includ
effort
determin
structur
ligandbound
viral
rna
complex
identifi
uwnmr
group
togeth
commun
collabor
noncanon
macromolecular
repres
groundbreak
effort
expand
rang
biolog
target
amen
drug
target
repres
effort
better
understand
biolog
mechan
essenti
growth
prolifer
infecti
diseas
organ
methodolog
use
within
ssgcid
clone
express
test
protein
product
crystal
structur
determin
describ
previous
myler
et
al
detail
recent
improv
describ
accompani
articl
target
enter
ssgcid
pipelin
fig
clone
ssgcid
standard
bacteri
express
vector
pcr
amplif
genom
dna
cdna
tier
rel
small
percentag
target
plasmid
come
directli
collabor
tier
clone
use
gene
synthesi
tier
multipl
rescu
pathway
tier
allow
increas
success
either
express
purif
target
priorit
communityrequest
target
purifi
protein
hand
crystal
trial
set
standard
screen
use
two
sparsematrix
screen
two
gridcondit
screen
addit
substanti
number
ssgcid
protein
screen
use
microcapillari
protein
crystal
system
mpc
develop
protein
structur
initi
psi
technolog
center
gerdt
et
al
highprior
smallmolecularweight
target
fail
crystal
select
nmrbase
analysi
structur
determin
pnnl
uwnmr
tier
everi
uniqu
macromolecular
structur
solv
ssgcid
model
coordin
structur
factor
deposit
protein
data
bank
http
wwwpdborg
provid
broadest
possibl
public
access
berman
et
al
everi
apoprotein
structur
success
solv
bioinformat
process
attempt
find
put
cofactor
inhibitor
ligand
cocrystal
trial
process
employ
biochem
search
enzymereact
substrat
cofactor
mine
databas
contain
ligand
potenti
inhibitor
interact
chemic
abstract
servic
ca
number
identifi
use
queri
vendor
databas
order
addit
target
ligandcomplex
studi
ssgcid
annual
select
small
number
highimpact
target
complet
fragmentsoflif
librari
screen
tier
begley
davi
et
al
davi
et
al
librari
contain
metabolit
bioisoster
small
molecul
design
mimic
compound
found
within
natur
metabolom
studi
highprior
ssgcid
target
led
refin
fragmentbas
screen
techniqu
nmr
spectroscopi
begley
davi
et
al
xray
crystallographi
begley
hartley
et
al
lastli
rna
target
enter
tier
protein
complex
enter
tier
special
protocol
adapt
pipelin
product
class
macromolecul
fig
date
target
approv
entri
ssgcid
structuredetermin
pipelin
fig
includ
either
nomin
claim
scientif
commun
ssgcid
clone
total
target
express
solubl
protein
prepar
high
puriti
cell
extract
yield
crystal
amen
diffract
result
xray
structur
target
heteronuclear
singlequantum
coher
hsqc
spectra
acquir
addit
target
led
complet
solutionst
structur
determin
standard
proteinbas
nmr
experi
differ
target
led
structur
submit
pdb
target
contain
bound
ligand
overal
structuredetermin
success
rate
bacteri
eukaryot
viral
target
clone
ssgcid
current
stand
success
rate
vari
consider
genera
tabl
solubl
rate
surprisingli
similar
prokaryot
eukaryot
versu
respect
bacteria
borrelia
rickettsia
number
eukaryot
cryptosporidium
encephalitozoon
entamoeba
giardia
toxoplasma
perform
rel
poorli
interestingli
purif
success
rate
lower
prokaryot
eukaryot
may
result
larg
number
solubl
burkholderia
target
yet
purifi
crystal
diffract
rate
eukaryot
protein
lower
respect
prokaryot
respect
howev
highqual
diffract
data
obtain
rate
structur
solut
similar
kingdom
import
mandat
ssgcid
provid
threedimension
protein
structuredetermin
servic
scientif
commun
charg
target
nomin
requestor
may
submit
onlin
http
wwwssgcidorghomecommunityasp
nomin
given
highest
prioriti
ssgcid
pipelin
sinc
begin
project
commun
request
receiv
group
approv
enter
ssgcid
pipelin
see
tabl
fig
request
receiv
prepar
manuscript
thu
still
process
submiss
niaid
entri
pipelin
includ
commun
request
uniqu
target
intern
select
ssgcid
subsequ
request
member
scientif
commun
consequ
target
convert
commun
request
protein
structur
solv
ssgcid
submit
protein
data
bank
target
statu
protocol
submit
psi
targetdb
pepcdb
structur
submit
pdb
ssgcid
includ
structur
differ
communityrequest
target
see
tabl
ssgcid
structur
provid
previous
unavail
resourc
research
work
mani
pathogen
sinc
repres
substanti
portion
pdb
entri
number
genera
exampl
ssgcid
solv
pdb
entri
anaplasma
ten
ehrlichia
nine
rickettsia
six
entri
babesia
seven
entri
brucella
entri
bartonella
entri
coccidioid
eight
ssgcid
work
close
member
scientif
commun
publish
protein
structur
data
produc
consortium
result
number
collabor
public
yamada
et
al
edward
et
al
jaff
et
al
zhang
et
al
buchko
et
al
li
et
al
b
moreno
et
al
clone
produc
ssgcid
made
avail
biodefens
emerg
infect
research
resourc
repositori
beir
http
wwwbeiresourcesorg
date
clone
avail
order
deposit
quarter
protein
purifi
singl
final
peak
sizeexclus
chromatographi
mg
quantiti
produc
ssgcid
order
onlin
ssgcid
protein
sampl
distrbut
system
ssgcidpsd
psd
site
http
wwwssgcidproteinsorg
partner
emerald
biosystem
access
bei
resourc
websit
fall
cost
endus
protein
nomin
charg
cover
ship
dri
ice
time
write
ssgcid
submit
structur
pdb
protein
encod
bacteria
parasit
virus
caus
human
infecti
diseas
current
rate
solv
structur
approxim
two
new
deposit
everi
week
put
us
track
exceed
project
fiveyear
goal
csgid
sister
center
ssgcid
solv
structur
similar
pace
thu
anticip
togeth
ssgcid
csgid
submit
structur
infecti
diseas
drug
target
pdb
end
fiveyear
contract
period
late
mani
organ
repres
vast
major
protein
structur
avail
thu
provid
heretofor
unavail
opportun
research
exploit
structurebas
drugdesign
approach
order
develop
novel
chemotherapeut
agent
diseas
ssgcid
commit
engag
infecti
diseas
research
commun
collabor
maxim
potenti
exploit
recent
advanc
structur
genom
follow
articl
special
issu
serv
commun
ssgcid
progress
engend
even
interest
scientif
commun
volum
acta
crystallographica
section
f
repres
uniqu
perspect
ssgcid
compris
laboratori
structur
commun
prepar
entir
scientist
work
within
consortium
volum
contain
sever
methodolog
paper
provid
detail
highthroughput
pipelin
ssgcid
synthet
gene
construct
gene
compos
softwar
fusion
tag
cleavag
method
maximum
yield
largevolum
protein
express
special
instrument
parallel
protein
purif
crystal
specif
choi
cowork
show
screen
imac
recoveri
immobil
metalaffin
chromatographi
earli
highthroughput
screen
later
largescal
express
screen
help
identifi
protein
like
success
upscal
purif
crystal
trial
choi
et
al
addit
bryan
cowork
demonstr
proteas
cleavag
improv
chanc
given
protein
produc
structur
bryan
et
al
structur
commun
volum
cover
broad
rang
categori
b
c
pathogen
includ
bacteri
rickettsia
prowazekii
ehrlichia
chaffeensi
burkholderia
pseudomallei
eukaryot
giardia
lamblia
coccidioid
immiti
babesia
bovi
cryptosporidium
parvum
pathogen
repres
one
protein
structur
avail
organ
pdb
mani
instanc
commun
compar
apo
structur
protein
one
ligandbound
complex
includ
produc
fragment
screen
obtain
use
explicit
transitionst
mimet
compar
structur
investig
solutionst
crystal
form
serv
enhanc
understand
catalyt
mechan
target
provid
basi
ask
question
outset
ration
structurebas
drugdesign
research
